Twiggy's Invex Therapeutics | The Imminent Coin Flip, page-55

Not gonna lie that $1.30 raise to secure 30 mill was a blessing in disguise and just goes to show how good our mgmt team is.

There are some bios out there getting absolutely slaughtered as they have only a couple of quarters left in cash and need to raise 10-20 mill for the next phase. Considering how difficult the market is atm getting cash is becoming nearly quite impossible especially that amount. Alot of these bios may delist soon and we will only see cashed up bios left on the ASX or ones that are already successful nearing the end of their trials.

Less bios means less competition on the ASX for funds in the biospace sector.

Very grateful IXC is in this position especially in a PHASE 3 trial as well.

Another big tick on this mgmt team!